If genetic heterogeneity is the cause of this variability in Dazl−/− mice phenotypes (Saunders et al., 2003), this raises the question as to whether genetic background may also influence our understanding of DAZL-deficiency phenotypes in humans. This evidence concerns the gene DAZL and hyperinsulinemic hypoglycemia, familial, 4.